We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LND:NYSEBrasilagro Brazilian Agric Real Estate Co Sponsored Analysis

Data as of 2026-05-19 - not real-time

$3.75

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

BrasilAgro (LND) trades at roughly $3.75, dramatically below the DCF‑derived fair value of about $37.86, suggesting a deep valuation gap. Revenue is expanding at a robust 24.8% rate, yet the company posts a gross margin of just 4.4% and an operating margin of –8.4%, indicating profitability challenges. The balance sheet is strained with $1.32 B of debt and a debt‑to‑equity ratio exceeding 60, while cash reserves sit near $54 M, and free cash flow remains negative. Dividend sustainability is questionable; a 3.7% yield is supported by a payout ratio over 110% despite negative earnings.
Technically, the stock sits near its $3.67 support level, with the 20‑day SMA (3.87) slightly above price and the 200‑day SMA (3.85) roughly flat, signaling a neutral trend. RSI at 39 points to mild oversold conditions, but the MACD is bearish, and volume is on a downtrend, tempering short‑term upside expectations. The combination of high volatility (≈25% 30‑day) and low beta (≈0.56) reflects a stock that moves sharply but is less correlated with broader markets, while geographic exposure to Brazil, Paraguay and Bolivia adds medium‑to‑high regional risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish MACD histogram
  • Decreasing trading volume
  • Price hovering just above recent support

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • Strong revenue growth but persistent negative margins
  • High debt load relative to equity
  • Dividend payout exceeding earnings

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Significant valuation discount to DCF fair value
  • Operating cash flow remains positive
  • Exposure to long‑term agribusiness demand in South America

Key Metrics & Analysis

Financial Health

Revenue Growth24.80%
Profit Margin-0.16%
ROE-0.07%
ROA-1.32%
Debt/Equity63.66
P/B Ratio0.9
Op. Cash Flow$204.5M
Free Cash Flow$-175079248

Technical Analysis

TrendNeutral
RSI39.7
Support$3.67
Resistance$4.14
MA 20$3.87
MA 50$4.03
MA 200$3.85
MACDBearish
VolumeDecreasing
Fear & Greed Index89.61

Valuation

Fair Value$37.86
GradeUndervalued
TypeGrowth
Dividend Yield3.70%

Risk Assessment

Beta0.57
Volatility24.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.